Adma Biologics | ADMA - 贷款资金

金融业

USD

USD 624.24M

现金及等价物

USD 87.63M

USD 50.4M

USD 466.51M

USD 69.54M

USD 83.12M

USD 62.75M

USD 73.59M

624

EPS每股收益

USD 0.2

股本和储备

USD 477.32M

USD 88.82M

债务利息支出

USD 1.63M

USD 376K

USD 69.33M

USD 3.46B

USD 49.38M

USD 76.41M

USD 62.75M

普通股股本

USD 237.88M

29.73

USD 61.59M

USD 139.16M

销售和管理费用

USD 20.19M

USD 206.47M

贸易债权人

USD 22.52M

应收帐款人

USD 158.43M

	贷款资金	更改		日
Adma Biologics	USD 69.33M		750K	2025-12
Alnylam Pharmaceuticals	USD 2.48B		1.44B	2025-12
BioCryst Pharmaceuticals	USD 428.67M		234.31M	2025-12
Minerva Neurosciences	USD 0		86.58M	2024-09
Novavax	USD 246.3M		200K	2025-12
Omeros	USD 403.72M		27.2M	2024-06
Takeda	JPY 4.27T		81.29B	2025-12